发表研究结果有使用 ab52894?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab52894 被引用在 55 文献中.

  • Abou-Antoun TJ  et al. Molecular and functional analysis of anchorage independent, treatment-evasive neuroblastoma tumorspheres with enhanced malignant properties: A possible explanation for radio-therapy resistance. PLoS One 13:e0189711 (2018). PubMed: 29298329
  • Emmerson E  et al. Salivary glands regenerate after radiation injury through SOX2-mediated secretory cell replacement. EMBO Mol Med N/A:N/A (2018). PubMed: 29335337
  • Alamri AM  et al. Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing. Dis Model Mech 11:N/A (2018). PubMed: 29419396
  • Wasén C  et al. Epidermal growth factor receptor function in the human urothelium. Int Urol Nephrol 50:647-656 (2018). WB, IHC-P . PubMed: 29508172
  • Zhang Z  et al. Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice. Mol Vis 24:274-285 (2018). PubMed: 29643724
  • Zhang Y  et al. Netrin-1 promotes diabetic corneal wound healing through molecular mechanisms mediated via the adenosine 2B receptor. Sci Rep 8:5994 (2018). PubMed: 29662125
  • Fontana AO  et al. Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence. J Neurooncol 133:497-507 (2017). PubMed: 28500562
  • Oldrini B  et al. EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer. Nat Commun 8:2035 (2017). ICC/IF ; Human . PubMed: 29229958
  • Petersen I  et al. EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC - Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP®). Pathol Res Pract 213:1530-1535 (2017). PubMed: 29108919
  • Chen YC  et al. Laser-emission imaging of nuclear biomarkers for high-contrast cancer screening and immunodiagnosis. Nat Biomed Eng 1:724-735 (2017). IHC ; Human . PubMed: 29204310
  • Williams V  et al. Detection of IKKe by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis. BMC Cancer 17:356 (2017). PubMed: 28532474
  • Chen J  et al. A role for ErbB signaling in the induction of reactive astrogliosis. Cell Discov 3:17044 (2017). PubMed: 29238610
  • Xu T  et al. Oridonin enhancesin vitroanticancer effects of lentinan in SMMC-7721 human hepatoma cells through apoptotic genes. Exp Ther Med 14:5129-5134 (2017). PubMed: 29201227
  • Huang XY  et al. Missing-in-metastasis B (MIM-B) combined with caveolin-1 promotes metastasis of hepatocellular carcinoma. Oncotarget 8:95450-95465 (2017). PubMed: 29221140
  • Hsu PY  et al. Cordycepin and a preparation fromCordyceps militarisinhibit malignant transformation and proliferation by decreasing EGFR and IL-17RA signaling in a murine oral cancer model. Oncotarget 8:93712-93728 (2017). PubMed: 29212184
  • Rübsam M  et al. E-cadherin integrates mechanotransduction and EGFR signaling to control junctional tissue polarization and tight junction positioning. Nat Commun 8:1250 (2017). PubMed: 29093447
  • Li H  et al. RPN2 promotes colorectal cancer cell proliferation through modulating the glycosylation status of EGFR. Oncotarget 8:72633-72651 (2017). PubMed: 29069815
  • Ran H  et al. Nuclear Shp2 directs normal embryo implantation via facilitating the ERa tyrosine phosphorylation by the Src kinase. Proc Natl Acad Sci U S A 114:4816-4821 (2017). PubMed: 28424251
  • Cheng Z  et al. MicroRNA-145 down-regulates mucin 5AC to alleviate airway remodeling and targets EGFR to inhibit cytokine expression. Oncotarget 8:46312-46325 (2017). PubMed: 28564633
  • Mehner C  et al. EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review. Genes Cancer 8:589-599 (2017). PubMed: 28740577
  • Yang HK  et al. Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF-A pathway. Oncol Lett 14:4021-4028 (2017). PubMed: 28943909
  • Liang J  et al. Epstein-Barr virus-encoded LMP2A stimulates migration of nasopharyngeal carcinoma cells via the EGFR/Ca(2+)/calpain/ITGß4 axis. Biol Open 6:914-922 (2017). PubMed: 28512118
  • Emmerson E  et al. SOX2 regulates acinar cell development in the salivary gland. Elife 6:N/A (2017). ICC/IF ; Mouse, Human . PubMed: 28623666
  • Guan G  et al. Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells. Tumour Biol 39:1010428317691740 (2017). PubMed: 28347232
  • Tang H  et al. Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface. Nat Commun 8:14909 (2017). IHC . PubMed: 28416796
  • Hessmann E  et al. NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation. Stem Cells Int 2016:5272498 (2016). IHC . PubMed: 26697077
  • He F  et al. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. Oncotarget 7:37000-37012 (2016). WB . PubMed: 27203742
  • Derangère V  et al. Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer? Oncotarget 7:9309-21 (2016). WB . PubMed: 26824184
  • Chen CC  et al. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation. Oncogene 35:1314-23 (2016). WB . PubMed: 26028023
  • Wang G  et al. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPAR? signalling pathway. Sci Rep 6:35783 (2016). WB . PubMed: 27779188
  • Ambrogio C  et al. In vivo oncogenic conflict triggered by co-existing KRAS and EGFR activating mutations in lung adenocarcinoma. Oncogene N/A:N/A (2016). PubMed: 27775074
  • Jaako K  et al. Prolyl endopeptidase is involved in the degradation of neural cell adhesion molecules in vitro. J Cell Sci 129:3792-3802 (2016). PubMed: 27566163
  • Zhang Y  et al. Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC. Oncol Lett 12:3241-3249 (2016). IHC-P ; Mouse . PubMed: 27899989
  • Xu J  et al. HER2 overexpression reverses the relative resistance of EGFR-mutant H1975 cell line to gefitinib. Oncol Lett 12:5363-5369 (2016). WB ; Human . PubMed: 28105244
  • Wang J  et al. GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis. Nat Commun 7:11795 (2016). IHC . PubMed: 27273304
  • Lu YY  et al. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/ß-catenin pathway and receptor tyrosine kinases. J Pharm Pharmacol 67:1393-405 (2015). WB ; Human . PubMed: 26076716
  • Sethi MK  et al. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation. Glycobiology 25:1064-78 (2015). PubMed: 26085185
  • Fu Y  et al. Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype. Sci Rep 5:13347 (2015). PubMed: 26289340
  • Mehner C  et al. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers. Oncotarget 6:35737-54 (2015). WB . PubMed: 26437224
  • Shuai S  et al. TIP30 nuclear translocation negatively regulates EGF-dependent cyclin D1 transcription in human lung adenocarcinoma. Cancer Lett 354:200-9 (2014). PubMed: 25135222
  • Samkoe KS  et al. Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach. Cancer Res 74:7465-74 (2014). PubMed: 25344226
  • Brand TM  et al. Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer. Mol Cancer Ther 13:1356-68 (2014). PubMed: 24634415
  • Iida M  et al. Sym004, a novel EGFR antibody mixture, can overcome acquired resistance to cetuximab. Neoplasia 15:1196-206 (2013). PubMed: 24204198
  • Brand TM  et al. Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3. PLoS One 8:e71518 (2013). WB ; Human . PubMed: 23951180
  • Sollome JJ  et al. HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4). Cell Signal 26:70-82 (2013). Human . PubMed: 24036211
  • de Castro CV  et al. Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome. Hum Pathol 44:1747-55 (2013). ICC/IF ; Human . PubMed: 23618355
  • Yuan Y  et al. Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways. Biochim Biophys Acta 1830:4907-16 (2013). PubMed: 23850473
  • Giles KM  et al. Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib. Mol Cancer Ther 12:2541-58 (2013). WB ; Human . PubMed: 24026012
  • Clark PA  et al. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. Neoplasia 14:420-8 (2012). IF . PubMed: 22745588
  • Modena P  et al. Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis. Neuro Oncol 14:1346-56 (2012). IHC ; Human . PubMed: 23076205
  • Raina D  et al. Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells. Mol Cancer Ther 10:806-16 (2011). IP ; Human . PubMed: 21421804
  • Burga LN  et al. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. Breast Cancer Res 13:R30 (2011). WB, ICC/IF ; Human . PubMed: 21396117
  • Bade LK  et al. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor. J Cell Sci 124:3106-17 (2011). WB ; Mouse . PubMed: 21868365
  • Choi KY  et al. Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc Natl Acad Sci U S A 108:15219-24 (2011). WB ; Mouse . PubMed: 21896768
  • Restivo G  et al. IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. EMBO J 30:4571-85 (2011). PubMed: 21909072

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册